These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8853037)
1. Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-ras-2 and p53 analysis. Przygodzki RM; Koss MN; Moran CA; Langer JC; Swalsky PA; Fishback N; Bakker A; Finkelstein SD Am J Clin Pathol; 1996 Oct; 106(4):487-92. PubMed ID: 8853037 [TBL] [Abstract][Full Text] [Related]
2. Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies. Forest F; Yvorel V; Karpathiou G; Stachowicz ML; Vergnon JM; Fournel P; Tiffet O; Trombert B; Péoc'h M Hum Pathol; 2016 Mar; 49():99-106. PubMed ID: 26826416 [TBL] [Abstract][Full Text] [Related]
3. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
4. Correlation between squamous cell carcinoma of the lung and human papillomavirus infection and the relationship to expression of p53 and p16. Fan X; Yu K; Wu J; Shao J; Zhu L; Zhang J Tumour Biol; 2015 Apr; 36(4):3043-9. PubMed ID: 25544708 [TBL] [Abstract][Full Text] [Related]
5. Pleomorphic (giant and/or spindle cell) carcinoma of lung shows a high percentage of variant CYP1A12. Przygodzki RM; Koss MN; O'Leary TJ Mol Diagn; 2001 Jun; 6(2):109-15. PubMed ID: 11468695 [TBL] [Abstract][Full Text] [Related]
6. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions. El Hag M; Schmidt L; Roh M; Michael CW Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356 [TBL] [Abstract][Full Text] [Related]
7. [p53 alterations in human lung cancer and their correlation with clinicopathological features and prognosis]. Zhang J; Zheng J; Fang W Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):286-9. PubMed ID: 11244999 [TBL] [Abstract][Full Text] [Related]
9. Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases. Weissferdt A; Kalhor N; Rodriguez Canales J; Fujimoto J; Wistuba II; Moran CA Hum Pathol; 2017 Jan; 59():1-9. PubMed ID: 27569293 [TBL] [Abstract][Full Text] [Related]
10. hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment. Vageli DP; Zaravinos A; Daniil Z; Dahabreh J; Doukas SG; Spandidos DA; Gourgoulianis KI; Koukoulis GK Int J Biol Markers; 2013 Jan; 27(4):e400-4. PubMed ID: 22865300 [TBL] [Abstract][Full Text] [Related]
11. The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix. Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Finkelstein SD Int J Gynecol Pathol; 1997 Oct; 16(4):301-6. PubMed ID: 9421067 [TBL] [Abstract][Full Text] [Related]
12. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Sy SM; Wong N; Lee TW; Tse G; Mok TS; Fan B; Pang E; Johnson PJ; Yim A Eur J Cancer; 2004 May; 40(7):1082-94. PubMed ID: 15093586 [TBL] [Abstract][Full Text] [Related]
13. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria. Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808 [TBL] [Abstract][Full Text] [Related]
14. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis. Holst VA; Finkelstein S; Colby TV; Myers JL; Yousem SA Am J Surg Pathol; 1997 Jul; 21(7):801-11. PubMed ID: 9236836 [TBL] [Abstract][Full Text] [Related]
15. EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy. Chang YL; Wu CT; Shih JY; Lee YC Ann Surg Oncol; 2011 Oct; 18(10):2952-60. PubMed ID: 21409490 [TBL] [Abstract][Full Text] [Related]
16. K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Pelosi G; Scarpa A; Manzotti M; Veronesi G; Spaggiari L; Fraggetta F; Nappi O; Benini E; Pasini F; Antonello D; Iannucci A; Maisonneuve P; Viale G Mod Pathol; 2004 May; 17(5):538-46. PubMed ID: 14990969 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma. Hwang DH; Szeto DP; Perry AS; Bruce JL; Sholl LM Arch Pathol Lab Med; 2014 May; 138(5):626-35. PubMed ID: 23738762 [TBL] [Abstract][Full Text] [Related]
18. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer? Vincenten JP; Smit EF; Grünberg K; Postmus PE; Snijders PJ; Witte BI; Heideman DA; Thunnissen E Lung Cancer; 2015 Jul; 89(1):19-26. PubMed ID: 25982011 [TBL] [Abstract][Full Text] [Related]
19. Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma. Sousa V; Reis D; Silva M; Alarcão AM; Ladeirinha AF; d'Aguiar MJ; Ferreira T; Caramujo-Balseiro S; Carvalho L Virchows Arch; 2016 Aug; 469(2):173-82. PubMed ID: 27194548 [TBL] [Abstract][Full Text] [Related]
20. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer. Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]